Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15681123
[patent_doc_number] => 20200095225
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-03-26
[patent_title] => NEW ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/307193
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307193 | Antibacterial compounds | Jun 4, 2017 | Issued |
Array
(
[id] => 15681123
[patent_doc_number] => 20200095225
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-03-26
[patent_title] => NEW ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/307193
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307193 | Antibacterial compounds | Jun 4, 2017 | Issued |
Array
(
[id] => 13328363
[patent_doc_number] => 20180215719
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-08-02
[patent_title] => SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER
[patent_app_type] => utility
[patent_app_number] => 15/606970
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606970
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606970 | SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder | May 25, 2017 | Issued |
Array
(
[id] => 13328363
[patent_doc_number] => 20180215719
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-08-02
[patent_title] => SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER
[patent_app_type] => utility
[patent_app_number] => 15/606970
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606970
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606970 | SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder | May 25, 2017 | Issued |
Array
(
[id] => 11956013
[patent_doc_number] => 20170260165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => '2-Imidazolyl-Pyrimidine Scaffolds as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase'
[patent_app_type] => utility
[patent_app_number] => 15/602833
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4517
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602833 | 2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase | May 22, 2017 | Issued |
Array
(
[id] => 16230499
[patent_doc_number] => 10738037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
[patent_app_type] => utility
[patent_app_number] => 16/301826
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10845
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301826 | Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide | May 17, 2017 | Issued |
Array
(
[id] => 14372307
[patent_doc_number] => 20190160066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => THERAPEUTIC AGENT FOR LUNG CANCER THAT HAS ACQUIRED EGFR-TKI RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 16/302207
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302207 | Therapeutic agent for lung cancer that has acquired EGFR-TKI resistance | May 16, 2017 | Issued |
Array
(
[id] => 11866083
[patent_doc_number] => 20170233369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/586657
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23432
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586657
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586657 | Metalloenzyme inhibitor compounds as fungicides | May 3, 2017 | Issued |
Array
(
[id] => 14309427
[patent_doc_number] => 20190144417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/098245
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098245 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | May 3, 2017 | Issued |
Array
(
[id] => 11866145
[patent_doc_number] => 20170233429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/581834
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43524
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581834
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581834 | Thionucleoside derivative or salt thereof, and pharmaceutical composition | Apr 27, 2017 | Issued |
Array
(
[id] => 16770811
[patent_doc_number] => 10981899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Inhibitors of soluble adenylyl cyclase
[patent_app_type] => utility
[patent_app_number] => 16/097087
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 14
[patent_no_of_words] => 13328
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097087 | Inhibitors of soluble adenylyl cyclase | Apr 27, 2017 | Issued |
Array
(
[id] => 14182649
[patent_doc_number] => 20190111029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => TREATMENT OF IMPULSIVITY-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/097239
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097239
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097239 | Treatment of impulsivity-related disorders | Apr 26, 2017 | Issued |
Array
(
[id] => 12205794
[patent_doc_number] => 20180051015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => '3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH'
[patent_app_type] => utility
[patent_app_number] => 15/499824
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 156576
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/499824 | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | Apr 26, 2017 | Issued |
Array
(
[id] => 14230345
[patent_doc_number] => 20190127345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => NEGATIVE PHOTOCHROMIC MATERIALS WITH TUNABLE PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/096063
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096063 | NEGATIVE PHOTOCHROMIC MATERIALS WITH TUNABLE PROPERTIES | Apr 25, 2017 | Abandoned |
Array
(
[id] => 15227455
[patent_doc_number] => 10501437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
[patent_app_type] => utility
[patent_app_number] => 16/097506
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24408
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097506 | Crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide | Apr 24, 2017 | Issued |
Array
(
[id] => 14230417
[patent_doc_number] => 20190127381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SUBSTITUTED FUSED PYRIMIDINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/095597
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095597 | SUBSTITUTED FUSED PYRIMIDINONE COMPOUNDS | Apr 24, 2017 | Abandoned |
Array
(
[id] => 12051142
[patent_doc_number] => 20170327485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 15/492719
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61479
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492719 | SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | Apr 19, 2017 | Abandoned |
Array
(
[id] => 11834574
[patent_doc_number] => 20170216290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME'
[patent_app_type] => utility
[patent_app_number] => 15/488795
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 276576
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488795 | Heteroaryl compounds useful as inhibitors of SUMO activating enzyme | Apr 16, 2017 | Issued |
Array
(
[id] => 13139653
[patent_doc_number] => 10087147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => 5-(trifluoromethyl)pyrimidine derivatives and method for producing same
[patent_app_type] => utility
[patent_app_number] => 15/488076
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6335
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488076
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488076 | 5-(trifluoromethyl)pyrimidine derivatives and method for producing same | Apr 13, 2017 | Issued |
Array
(
[id] => 14018907
[patent_doc_number] => 20190071447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => PYRAZOLOPYRIMIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/093565
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093565 | Pyrazolopyrimidine derivatives | Apr 9, 2017 | Issued |